Clinical Trials Logo

Fetal Macrosomia clinical trials

View clinical trials related to Fetal Macrosomia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05760768 Completed - Clinical trials for Gestational Weight Gain

The Effect of Individualized Exercise Guidance on Pregnancy Outcome

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

A single center, randomized controlled trial was conducted to investigate whether individualized exercise guidance was more effective in improving pregnancy outcomes in normal pregnant women. What's more, the trial was also conducted to find out whether there is a mediating effect between prenatal exercise and pregnancy outcomes.

NCT ID: NCT04536753 Completed - Ultrasound Clinical Trials

The Utility of Customised Growth Charts for Identifying Macrosomia and the Effect of Intervention

Start date: January 1, 2018
Phase:
Study type: Observational

Best management of suspected large for gestational age (LGA) fetuses is unclear. In some hospitals women with an LGA fetus by customised growth charts are are offered earlier induction. This study aimed to examine scan accuracy for this group and the outcome with intervention.

NCT ID: NCT03726697 Completed - Premature Infant Clinical Trials

Effect of Tahneek on Hypoglycemia in Newborn Infants

THIN
Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Tahneek is an Arabic word which means putting something sweet such as dates, in the infant's mouth after the birth. Neonatal hypoglycemia is common in the first few days after birth. Up to 15 % of normal newborn babies will have low blood glucose concentrations. It has been demonstrated that treatment of neonatal hypoglycemia with oral dextrose gel was more effective than feeding alone in reversing the hypoglycemia, and also reduced the rate of NICU admission. investigators study is using dates to asses its effect on hypoglycemia in infants at risk.

NCT ID: NCT03232294 Completed - Fetal Macrosomia Clinical Trials

Fetal Front-abdominal Wall Thickness and Perinatal Outcome

Start date: April 1, 2016
Phase: N/A
Study type: Observational [Patient Registry]

Abnormal fetal development such as macrosomia can cause some complications on both fetus and mother.The measurement of fetal anterior abdominal wall thickness (FAWT) is an easy examination that it can be obtained during an examination of a pregnant woman by ultrasound. Macrosomia for fetus can lead to some morbidities. It can affect perinatal outcome and increase childbirth complications and operative birth. There are some studies scrutinizing the relationship between FAWT and diabetes in the literature. However there are few studies which scrutinize effect of FAWT on both abnormal fetal development and adverse perinatal outcomes in non-diabetic pregnancies and non high risk pregnancies. Hence the investigators wonder if FAWT can anticipate birth-weight or macrosomic infant or perinatal outcome regarding with macrosomia in the second trimester.

NCT ID: NCT03165643 Completed - Diabetes Clinical Trials

The DNA Methylation of ARHGEF11 in Macrosomia

Start date: March 6, 2014
Phase: N/A
Study type: Observational

Background Macrosomia at birth is associated with subsequent susceptibility to obesity, abnormal glucose metabolism, hypertension and dyslipidaemia. Epigenetic reprogramming has been reported to be involved in the development of human diseases caused by suboptimal environmental or nutritional factors. Objective The study was aiming to explore epigenetic mechanism influences on macrosomic infants exposed to intrauterine hyperglycemia. Design The investigators performed a genome-wide analysis of DNA methylation in cord blood from macrosomic infants born to women with gestational diabetes or infants with normal birth weight born to normal glucose-tolerant women in order to identify genes related to foetal growth or early adipose tissue development. The candidate genes were then validated using SEQUENOM MassARRAY after bisulfite conversion.

NCT ID: NCT03002246 Completed - Clinical trials for Fetal Growth Retardation

Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume

Start date: January 6, 2017
Phase:
Study type: Observational

This trial is a collaborative study between 4 sites worldwide. A total of 600 research subjects will be enrolled. We will investigate the validity of using 5D Limb Volume software to improve on estimated fetal weight predictions over a broad range of gestational ages. The purpose is to compare the accuracy and precision of birth weight predictions based on this new technology as compared to the current 2D birth weight prediction models.

NCT ID: NCT02713568 Completed - Fetal Macrosomia Clinical Trials

Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study)

Start date: March 8, 2016
Phase: N/A
Study type: Interventional

Macrosomia and growth restriction are important causes of perinatal morbidity, at or near to term. However, clear identification of 'at risk' foetuses is difficult and clinical estimates of fetal weight are poor. Historically, ultrasound has been used as a second line in such cases but the accuracy of this imaging modality in the mid- to late third trimester is also limited. Estimated fetal weight (EFW) is an important part of the clinical assessment and is used to guide obstetric interventions, when a fetus is small or large for dates. It frequently is the single most important component guiding interventions, such as induction of labour or Caesarean section. Due to the imprecision of ultrasound-derived EFW, particularly in cases of suspected macrosomia in the 3rd trimester, the investigators believe that these estimates should not be used to make important obstetric decisions regarding mode and timing of delivery and that a more accurate method of assessment could produce better outcomes by restricting interventions to those foetuses at greatest risk. Some publications have already demonstrated that magnetic resonance (MR) imaging derived-EFW close to delivery, is more accurate than ultrasound The goal of the present study is thus to compare the performance of magentic resonance imaging derived-EFW, versus ultrasound derived-EFW at 36 weeks of gestation, regarding the prediction of neonatal macrosomia.

NCT ID: NCT02643225 Completed - Clinical trials for Gestational Diabetes

The Role of Umbilical Cord Thickness in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus

Start date: April 2015
Phase: N/A
Study type: Observational

The aim of this work is the prediction of fetal macrosomia by measuring: 1. HbA1C. 2. Umbilical cord thickness. 3. Interventricular septum thickness.

NCT ID: NCT02523222 Completed - Hypoglycemia Clinical Trials

Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia

Start date: July 2016
Phase: N/A
Study type: Interventional

This will be a quasi-experimental study comparing blood glucose values 30 minutes after feeding alone or feeding + 40% dextrose gel in newborns at risk for transient neonatal hypoglycemia.

NCT ID: NCT01728766 Completed - Clinical trials for Small for Gestational Age at Delivery

Breast Milk Zinc Transfer to Appropriate- and Small-for-gestational-age Bangladeshi Infants

Start date: July 2006
Phase: N/A
Study type: Observational

Data collected from this study will provide information on the breast milk zinc concentration, maternal and infant zinc status, and transfer of zinc from mothers breast milk to infants during first six months of life.